Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a good first test in patients with isolated mediastinal lymphadenopathy (IML), one that might spare many…
NEW YORK (Reuters Health) – In real-world patients with diffuse large B-cell lymphoma (DLBCL), the most common subtype of non-Hodgkin lymphoma (NHL), adding rituximab to first-line chemotherapy improves…
NEW YORK (Reuters Health) – Patients treated in childhood for Hodgkin lymphoma or Wilms tumor are at particularly high risk for developing colorectal cancer at a relatively young…
NEW YORK (Reuters Health) – Preoperative hysteroscopy can be safely used as a diagnostic tool in women with endometrial cancer, according to a report in the April 30th…
NEW YORK (Reuters Health) – For localized renal tumors, partial nephrectomy confers a survival advantage and a lower risk of severe chronic kidney disease (CKD) after surgery, relative…
NEW YORK (Reuters Health) – Patients younger than 50 with colon cancer derive similar benefit from adjuvant chemotherapy as older patients, according to study results reported in the…
NEW YORK (Reuters Health) – Dyspnea in patients with malignant pleural effusion is relieved to a similar degree with use of either indwelling pleural catheters (IPCs) or chest…
Brachytherapy has become increasingly and commonly used in the United States to treat breast cancer after a lumpectomy. Although this therapy and the standard treatment, whole breast irradiation,…
NEW YORK (Reuters Health) – Active surveillance (“watchful waiting”) of small renal masses offers short term results equivalent to those with immediate surgery, researchers from UK report in…
NEW YORK (Reuters Health) – Preoperative 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) can make a significant contribution to staging for locally advanced gastric cancer, according to a report in…
